Vion Pharmaceuticals INC
SEC CIK 944522 · VION · last insider filing 2009-09-10
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Miller William R | Director | filed 2006 - 2008 |
| Willis Gary K | Director | filed 2006 - 2008 |
| Sartorelli Alan | Director | filed 2006 - 2008 |
| Rakin Kevin | Director | filed 2007 - 2008 |
| Bickerstaff George | Director | filed 2006 - 2008 |
| Williams Ian | Director | filed 2006 - 2008 |
| Carter Stephen | Director | filed 2006 - 2007 |
| Kessman Alan | Director · Chief Executive Officer | filed 2006 - 2007 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| King Ivan | VP Research and Development | filed 2006 - 2009 |
| Cahill Ann Lee | VP Clinical Development | filed 2006 - 2009 |
| Lewis Tanya | Vice President, Regulatory | filed 2008 - 2008 |
| Hahne William | Vice President, Medical | filed 2008 - 2008 |
| Ryan Aileen | VP Regulatory Affairs | filed 2006 - 2007 |
| Tanguay James | VP of Chem Manuf & Control | filed 2007 - 2007 |
| Schmedlin Karen | VP Finance and CAO | filed 2006 - 2007 |
| Johnson Howard B | President and CFO | filed 2006 - 2007 |
| Fitzgerald Meghan | VP and Chief Business Officer | filed 2006 - 2007 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.